Cisco CFO: Services...
Services: Diversified Services
Myriad Genetics Inc. (MYGN: NASDAQ)
$33.06 0.13 | 0.39%
05/20/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with MYGN
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProJoel Greenblatt - Gotham Ca...
- ContributorStocks Rising On Unusual Vo...
- UserDesNews
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor4 Upgraded, Undervalued Stocks
- Contributor8 Health Care Buys Ahead of...
- ProClovis Capital Management
- ProRS Investment Management
Latest MYGN Headlines from TheStreet
- Stocks to Watch: Cisco, BlackBerry, Macy's 05.15.13 | 05:05 am
- Myriad Genetics To Present At The Bank Of America Merrill Lynch Health Care Conference 05.14.13 | 07:05 am
- Myriad Stock Hits New 52-Week High (MYGN) 05.10.13 | 12:05 pm
- Myriad Rises On Unusually High Volume (MYGN) 05.08.13 | 03:05 pm
- Today's Top Performers In Diversified Services 05.08.13 | 01:05 pm
- Myriad Genetics Reports Third Quarter Fiscal Year 2013 Results 05.07.13 | 04:05 pm
- Myriad Genetics Announces 2013 Analyst And Investor Day 05.02.13 | 04:05 pm
- Myriad To Present New Molecular Data For Patients With Prostate Cancer At The American Urological Association 2013 Annual Meeting 05.02.13 | 07:05 am
- Myriad Genetics To Announce Third Fiscal Quarter 2013 Results On Tuesday, May 7, 2013 04.18.13 | 04:04 pm
- Myriad Adopts RainDance's Thunderstorm Platform For Next-Generation Sequencing Based Hereditary Cancer Panel 04.17.13 | 04:04 pm
Press Releases for MYGN
- Myriad Genetics Receives The "Corporate Spirit Of Giving Award" From The Utah Philanthropy Day Committee - PR Newswire 11.02.11 | 07:11 am
- Rules-Based Medicine Reaches A Significant Milestone In Companion Diagnostic Program With Roche - PR Newswire 05.25.11 | 04:05 pm
- Rules-Based Medicine, Inc. (RBM) Partners With Institut Pasteur To Boost Innovation In Translational Research - PR Newswire 05.12.11 | 08:05 am
Partner Headlines for MYGN
- US judges cast doubts on DNA patents - Financial Times 04.15.13 | 06:04 pm
- Myriad Says US Supreme Court to Hear Isolated DNA Patent Case - Benzinga 11.30.12 | 04:11 pm
- Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics - Seeking Alpha 11.30.12 | 09:11 am
- Myriad Genetics - Momentum - Zacks 11.20.12 | 01:11 am
- Stocks Tack On More Gains; Cirrus Logic Retakes 200-Day Line - Investor's Business Daily 11.19.12 | 01:11 pm
- Parexel International Leads Medical Research Group - Investor's Business Daily 11.16.12 | 06:11 pm
- Leggett, Sherwin-Williams, DaVita Buck Weak Market - Investor's Business Daily 11.15.12 | 06:11 pm
- Strong 1Q from Myriad, Guidance Up - Analyst Blog - Zacks 11.06.12 | 09:11 am
- Stocks Improve In Late Trade; Nationstar Pares Losses - Investor's Business Daily 11.05.12 | 03:11 pm
- Myriad Remains Neutral - Analyst Blog - NASDAQ 09.21.12 | 07:09 pm
